Holen Sie sich die Stockscreener-App
9.13
1.56%
0.14
Handel nachbörslich:
9.76
0.63
+6.90%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt TLRY?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$8.99
Offen:
$8.92
24-Stunden-Volumen:
8.28M
Relative Volume:
0.78
Marktkapitalisierung:
$1.06B
Einnahmen:
$829.22M
Nettoeinkommen (Verlust:
$-248.96M
KGV:
-30.43
EPS:
-0.3
Netto-Cashflow:
$-92.10M
1W Leistung:
+1.11%
1M Leistung:
+26.81%
6M Leistung:
+54.67%
1J Leistung:
-33.36%
1-Tages-Spanne:
$8.79
$9.21
1-Wochen-Bereich:
$8.79
$9.85
52-Wochen-Spanne:
$3.507
$23.20
Tilray Brands Inc Stock (TLRY) Company Profile
Firmenname
Tilray Brands Inc
Sektor
Telefon
519.322.8800
Adresse
655 MADISON AVENUE, NEW YORK
Vergleichen Sie TLRY mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TLRY
Tilray Brands Inc
|
9.13 | 1.04B | 829.22M | -248.96M | -92.10M | -0.30 |
|
ZTS
Zoetis Inc
|
126.85 | 55.38B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
16.37 | 50.23B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
10.04 | 44.75B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
32.51 | 37.17B | 16.88B | 666.71M | 251.19M | 0.6132 |
|
UTHR
United Therapeutics Corp
|
490.83 | 21.69B | 3.08B | 1.24B | 1.07B | 25.61 |
Tilray Brands Inc Stock (TLRY) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-04-05 | Bestätigt | Alliance Global Partners | Neutral |
| 2022-11-02 | Eingeleitet | Bernstein | Mkt Perform |
| 2022-07-29 | Herabstufung | The Benchmark Company | Hold → Sell |
| 2022-03-04 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2021-11-18 | Eingeleitet | Barclays | Underweight |
| 2021-11-01 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2021-06-11 | Herabstufung | CIBC | Sector Outperform → Neutral |
| 2021-06-03 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2021-05-11 | Fortgesetzt | Cowen | Outperform |
| 2021-05-07 | Fortgesetzt | Jefferies | Buy |
| 2021-05-06 | Eingeleitet | Canaccord Genuity | Buy |
| 2021-04-28 | Fortgesetzt | BofA Securities | Buy |
| 2021-02-18 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2021-02-18 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2020-11-16 | Herabstufung | Jefferies | Hold → Underperform |
| 2020-11-11 | Herabstufung | Stifel | Hold → Sell |
| 2020-10-01 | Bestätigt | MKM Partners | Neutral |
| 2020-09-21 | Hochstufung | Jefferies | Underperform → Hold |
| 2020-05-12 | Bestätigt | The Benchmark Company | Buy |
| 2020-04-16 | Herabstufung | Jefferies | Hold → Underperform |
| 2020-04-09 | Herabstufung | Consumer Edge Research | Overweight → Equal Weight |
| 2020-02-24 | Herabstufung | Cowen | Outperform → Market Perform |
| 2020-01-13 | Eingeleitet | BofA/Merrill | Neutral |
| 2019-11-13 | Bestätigt | The Benchmark Company | Buy |
| 2019-11-05 | Eingeleitet | Cantor Fitzgerald | Neutral |
| 2019-10-22 | Bestätigt | Piper Jaffray | Overweight |
| 2019-09-20 | Eingeleitet | MKM Partners | Neutral |
| 2019-08-14 | Bestätigt | The Benchmark Company | Buy |
| 2019-07-17 | Eingeleitet | Ladenburg Thalmann | Neutral |
| 2019-06-28 | Eingeleitet | Consumer Edge Research | Overweight |
| 2019-06-06 | Eingeleitet | Stifel | Hold |
| 2019-06-05 | Eingeleitet | Oppenheimer | Perform |
| 2019-05-15 | Hochstufung | BMO Capital Markets | Underperform → Market Perform |
| 2019-05-13 | Eingeleitet | Alliance Global Partners | Neutral |
Alle ansehen
Tilray Brands Inc Aktie (TLRY) Neueste Nachrichten
Tilray shares jump 7% as Q2 revenue beats expectations in record quarter - Investing.com Canada
Tilray Brands Reports Q2 Cannabis Revenue Grew 5% - New Cannabis Ventures
Tilray Stock Fires Up After Record Q2 Earnings: Here's Why - Benzinga
Tilray Brands Delivers Record Q2 Fiscal 2026 Net Revenue - TradingView — Track All Markets
Earnings Flash (TLRY) Tilray Brands, Inc. Reports Q2 Revenue $217.5M, vs. FactSet Est of $210.9M - MarketScreener
Tilray Brands Delivers Record Q2 Fiscal 2026 Net Revenue of - GlobeNewswire
Best Cannabis Stocks To Follow TodayJanuary 8th - MarketBeat
Tilray Brands (TLRY.TO TSX) pre-market 08 Jan 2026: Q2 earnings may reset valuation - Meyka
Tilray Brands (2HQ.DE XETRA) down 5.05% before 08 Jan 2026 earnings: what to watch - Meyka
Tilray Brands (NASDAQ:TLRY) Trading Down 2.9%What's Next? - MarketBeat
Cannabis Stocks To Follow NowJanuary 7th - MarketBeat
Tilray Brands (TLRY) $9.49 intraday 06 Jan 2026: Jan 8 earnings may shift outlook - Meyka
Tilray (TLRY) Is About to Report Q2 Earnings. Here’s What to Expect from the Cannabis Stock - TipRanks
Tilray Brands (TLRY) Faces Earnings Headwinds - GuruFocus
Tilray Brands Q2 preview: Bottom line weakness to persist but reclassification offers hope - Seeking Alpha
Tilray Brands, Inc.'s (NASDAQ:TLRY) Shares Bounce 26% But Its Business Still Trails The Industry - 富途牛牛
Top Wall Street analysts adjust their outlook for Tilray Brands prior to Q2 earnings report - Bitget
Top Wall Street Forecasters Revamp Tilray Brands Expectations Ahead Of Q2 EarningsTilray Brands (NASDAQ:TLRY) - Benzinga
What analysts say about Tilray Brands Inc stockEarnings Season Recap & Fast Growing Capital Growth - earlytimes.in
Tilray’s Stock Tests Investor Patience As Cannabis Hype Fades And Diversification Bets Take Center - AD HOC NEWS
Tilray Shares Approach Critical Earnings Report Amid Market Caution - AD HOC NEWS
Tilray Brands Expected to Report Q2 Loss of $0.20 per Share - Intellectia AI
Tilray Brands (NASDAQ:TLRY) Shares Down 2.4%Here's What Happened - MarketBeat
Tilray Brands Inc. Stock Falls Tuesday, Underperforms Market - 富途牛牛
Tilray Q2: Optimism or Tough Truths? - Bitget
Tilray Q2: High Hopes or Harsh Reality?Tilray Brands (NASDAQ:TLRY) - Benzinga
Key facts: Trump calls for cannabis reclassification decision by January; Tilray stock falls 5.65% - TradingView — Track All Markets
Tilray Brands Readies for Q2 Earnings: Here's What You Should Know - Yahoo Finance
Tilray stock forms a risky pattern: Jan. 8 will be key - TradingView — Track All Markets
Tilray Brands Expands Dry January Offerings with Zero-Proof Spirits, Non-Alcoholic Beers and Hemp-Derived THC Beverages - The Manila Times
Tilray Brands Expands Dry January Offerings with Zero-Proof - GlobeNewswire
Tilray Shares Face Heightened Volatility Ahead of Earnings Release - AD HOC NEWS
Promising Cannabis Stocks To Add to Your WatchlistJanuary 3rd - MarketBeat
Top Companies Reporting Earnings This Week: Tilray, Applied Digital, and Others - Bitget
Tilray Shares Brace for Quarterly Earnings Release - AD HOC NEWS
Tilray Brands (NASDAQ:TLRY) Trading Down 2.3%Here's Why - MarketBeat
Top Stocks With Earnings This Week: Tilray, Applied Digital and More - Benzinga
(TLRY) Technical Patterns and Signals (TLRY:CA) - Stock Traders Daily
Best Cannabis Stocks To Add to Your WatchlistJanuary 5th - MarketBeat
Enhance Your Dry January with Mindful Sipping: Try Tilray’s Mollo and XMG Cannabis Beverages - markets.businessinsider.com
Stocks in play: Tilray Brands, Inc. - The Globe and Mail
Is Trump’s Cannabis Rescheduling Order Altering The Investment Case For Tilray Brands (TLRY)? - Yahoo Finance
Tilray (TLRY) Celebrates Dry January with Cannabis Drinks in Can - GuruFocus
Tilray’s Pivotal Earnings Report Approaches Amid Market Uncertainty - AD HOC NEWS
Tilray Brands (2HQ.DE) €0.68 pre-market 05 Jan 2026: Jan 8 earnings in focus - Meyka
Cannabis Stocks To Watch TodayJanuary 4th - MarketBeat
Tilray Shares Gain Momentum Ahead of Critical Quarterly Report - AD HOC NEWS
Top Cannabis Stocks To Watch TodayJanuary 1st - MarketBeat
Tilray Stock Faces Pivotal Test Amid Technical Weakness - AD HOC NEWS
(TLRY) Optimized Trading Opportunities (TLRY:CA) - Stock Traders Daily
Tilray Brands (NASDAQ:TLRY) Trading Up 7.6%Should You Buy? - MarketBeat
Finanzdaten der Tilray Brands Inc-Aktie (TLRY)
Umsatz
Nettogewinn
Free Cashflow
ENV
Tilray Brands Inc-Aktie (TLRY) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Merton Carl A | Chief Financial Officer |
Jul 31 '25 |
Option Exercise |
0.58 |
93,928 |
54,478 |
970,279 |
| Gendel Mitchell | Global General Counsel |
Jul 31 '25 |
Option Exercise |
0.58 |
93,928 |
54,478 |
742,069 |
| Gendel Mitchell | Global General Counsel |
Jul 31 '25 |
Buy |
0.58 |
6,000 |
3,496 |
698,287 |
| FALTISCHEK DENISE M | Chief Strategy Officer |
Jul 31 '25 |
Option Exercise |
0.58 |
93,928 |
54,478 |
874,564 |
| FALTISCHEK DENISE M | Chief Strategy Officer |
Jul 30 '25 |
Option Exercise |
0.61 |
261,194 |
159,328 |
919,069 |
| Herhalt Johann Michael | Director |
Jul 30 '25 |
Option Exercise |
0.61 |
124,378 |
75,871 |
239,930 |
| Looney Thomas P. | Director |
Jul 30 '25 |
Option Exercise |
0.61 |
124,378 |
75,871 |
354,416 |
| Hopkinson David G. | Director |
Jul 30 '25 |
Option Exercise |
0.61 |
124,378 |
75,871 |
335,563 |
| Clanachan David F | Director |
Jul 30 '25 |
Option Exercise |
0.61 |
124,378 |
75,871 |
236,880 |
| Persofsky Renah | Director |
Jul 30 '25 |
Option Exercise |
0.61 |
124,378 |
75,871 |
199,726 |
2.41%
1.75%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):